Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAMS: Tolerability of Acthar for MS Relapses
NCT02258217Completed
- Sponsor
- OhioHealth
- Start
- Jun 2014
- Primary completion
- Jun 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of corticotropin in multiple sclerosis (MS), sponsored by OhioHealth. Primary endpoints: Assessing Relapses in Multiple Sclerosis Activities of Daily Living, Assessing Relapses in Multiple Sclerosis Return to Previous Health and 6 more. Started Jun 2014; status: completed.
02
Drugs
corticotropin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02258217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02258217.